Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-mobility group box 1 serves as an inflammation driver of cardiovascular disease
Abd Wahid Haron, Wei Chen, Xuewen Wang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111555-111555
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Efferocytosis in atherosclerosis
Shaunak Adkar, Nicholas J. Leeper
Nature Reviews Cardiology (2024) Vol. 21, Iss. 11, pp. 762-779
Closed Access | Times Cited: 32
Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 29
Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice
Amany A. Alzokaky, Ahmed A. Al‐Karmalawy, Mohamed A. Saleh, et al.
Life Sciences (2023) Vol. 316, pp. 121390-121390
Closed Access | Times Cited: 24
High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases
Simona Taverna, Alessandro Tonacci, Maria Ferraro, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 849-849
Open Access | Times Cited: 36
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review
Cristina Panico, Benedetta Maria Bonora, Antonella Camera, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 20
PCSK9 Inhibition Reduces Depressive like Behavior in CUMS-Exposed Rats: Highlights on HMGB1/RAGE/TLR4 Pathway, NLRP3 Inflammasome Complex and IDO-1
Nevien Hendawy, Tala H. Salaheldin, Sally A. Abuelezz
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 1-2, pp. 195-207
Open Access | Times Cited: 19
Psychobiotics Lactiplantibacillus plantarum JYLP-326: Antidepressant-like effects on CUMS-induced depressed mouse model and alleviation of gut microbiota dysbiosis
Ruizhe Zhu, Xuanqi Zhao, Heng Wu, et al.
Journal of Affective Disorders (2024) Vol. 354, pp. 752-764
Closed Access | Times Cited: 6
Caveolin-1 and Atherosclerosis: Regulation of LDLs Fate in Endothelial Cells
Alessandra Puddu, Fabrizio Montecucco, Davide Maggi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8869-8869
Open Access | Times Cited: 13
Research progress in endothelial cell injury and repair
Yongpan Huang, Chong Song, Jianbin He, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
PARP1 Activation Induces HMGB1 Secretion Promoting Intestinal Inflammation in Mice and Human Intestinal Organoids
Roberta Vitali, Anna Barbara Mancuso, Francesca Palone, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7096-7096
Open Access | Times Cited: 11
Assessing platelet-derived extracellular vesicles for potential as therapeutic targets in cardiovascular diseases
Xin Xin, Rory R. Koenen
Expert Opinion on Therapeutic Targets (2025), pp. 1-12
Open Access
Research Progress of HGMB1 in the Diagnosis and Prognosis of Cardiovascular Disease Severity
丹 王
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1613-1619
Closed Access
New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses
Xiaobo Su, Yunjuan Sun, Aiguo Dai
APOPTOSIS (2025)
Open Access
Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases
Yang Yang, Ying Luan, Ruixia Yuan, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 19
KLF9 deficiency protects the heart from inflammatory injury triggered by myocardial infarction
Zhihong Chang, Hongkun Li
Korean Journal of Physiology and Pharmacology (2023) Vol. 27, Iss. 2, pp. 177-185
Open Access | Times Cited: 7
Combination of Taurine and Black Pepper Extract as a Treatment for Cardiovascular and Coronary Artery Diseases
Jordan Swiderski, Samy Sakkal, Vasso Apostolopoulos, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2562-2562
Open Access | Times Cited: 7
Sodium‐Glucose Co‐Transporter‐2 Inhibitor Empagliflozin Attenuates Sorafenib‐Induced Myocardial Inflammation and Toxicity
Shin-Huei Liu, Yu‐Cheng Ho, Wen‐Chin Lee, et al.
Environmental Toxicology (2024)
Closed Access | Times Cited: 2
Cardiac adverse effects of antiseizure medications
Gaetano Zaccara, Simona Lattanzi, Francesco Brigo
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 641-652
Closed Access | Times Cited: 17
Glycyrrhizic Acid Inhibits High-Mobility Group Box-1 and Homocysteine-Induced Vascular Dysfunction
Laura Kate Gadanec, Jan Andersson, Vasso Apostolopoulos, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3186-3186
Open Access | Times Cited: 4
Association between circulatory microRNA-218 expression, serum PCSK9 levels, inflammatory markers, and monocyte subsets in coronary artery disease patients: impact of statin therapy
Dina A. Desouky, Nahla Nosair, Dalia Elsayed Sherif, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Decoding vascular aging: implications for atherosclerosis progression and clinical intervention
Silumbwe Ceaser Wankumbu, Xiao‐Man Ji, Ming Xu
(2024), pp. 449-472
Open Access | Times Cited: 1
A Comprehensive Review of Molecular Mechanisms, Pharmacokinetics, Toxicology and Plant Sources of Juglanin: Current Landscape and Future Perspectives
Magdalena Rutkowska, Martyna Witek, Monika A. Olszewska
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10323-10323
Open Access | Times Cited: 1
PCSK9 and its relationship with HMGB1, TLR4, and TNFα in non-statin and statin-treated coronary artery disease patients
Dina A. Desouky, Nahla Nosair, Mohamed Kamal Salama, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
MiR-126-HMGB1-HIF-1 Axis Regulates Endothelial Cell Inflammation during Exposure to Hypoxia-Acidosis
Jinxue Liu, Eileen Wei, Jianqin Wei, et al.
Disease Markers (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 9
Role of High Mobility Group Box 1 in Cardiovascular Diseases
Souad Belmadani, Khalid Matrougui
Inflammation (2022) Vol. 45, Iss. 5, pp. 1864-1874
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top